Close

Analyst Ratings for Denali Therapeutics Inc. (DNLI)

DNLI Rating Summary

DNLI Price Target Summary

* Over Last 12-Mos
  |   Expand Research on DNLI
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $47.40 (+135.9%) * Over Last 12-Mos
Rating Score: 8.6 / 10   Percentile Rank: 88%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/13/2023 Citi David Hoang New Coverage Buy
(N/A)
32.00
(N/A)
18.24
(20.09)
10.14% Details
11/20/2023 JPMorgan Jessica Fye New Coverage Overweight
(N/A)
28.00
(N/A)
18.13
(20.09)
10.81% Details
Like DNLI Ratings? Also take a look at MRNA, OMGA, MCRB, FHTX

DNLI Ratings News